ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease
C. Michael Gibson gets the full story from Rasha Al-Lamee on one of the most talked about trials of 2017.
New at TCTMD? Register today!
Enter the email you used to register to reset your password.